Stereotactic Radiotherapy in Combination With the Immunoconjugate Trastuzumab Emtansine in Patients With HER2-Positive Oligometastatic Breast Cancer: Final Results of the Efficacy and Safety Study. Вопр. онкол. 2026, 72 (3), OF-2696. https://doi.org/10.37469/0507-3758-2026-72-3-OF-2696.